Therapeutic Asset Ratings
278 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Evorpacept
HER-2 Protein Overexpression
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
Metastatic Neoplasm
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
Progesterone-Receptor Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Evorpacept
PR-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Estrogen-Receptor Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Estrogen Receptor Positive Tumor
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
HER2 Low Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Neoplasm
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
HER-2 Protein Overexpression
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Metastatic Neoplasm
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
Progesterone-Receptor Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Fam-Trastuzumab Deruxtecan-Nxki
PR-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Tucatinib
Estrogen Receptor Positive Tumor
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Tucatinib
Neoplasm
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Tucatinib
HER-2 Protein Overexpression
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Tucatinib
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Tucatinib
Progesterone-Receptor Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Tucatinib
PR-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Zanidatamab
Estrogen-Receptor Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Zanidatamab
Estrogen Receptor Positive Tumor
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Zanidatamab
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare Collaborative
P1
CC
(43)
Showing 226 to 250 of 278 assets
Previous
Page 10 of 12
Next
